Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugate

Difei Qiua Chemical Process Development, Global Product Development and Supply, Bristol Myers Squibb Company, New Brunswick, NJ, USACorrespondence[email protected]

Yande Huanga Chemical Process Development, Global Product Development and Supply, Bristol Myers Squibb Company, New Brunswick, NJ, USA

Naresh Chennamsettyb Biologics Development, Global Product Development and Supply, Bristol Myers Squibb Company, New Brunswick, NJ, USA

Scott A. Millera Chemical Process Development, Global Product Development and Supply, Bristol Myers Squibb Company, New Brunswick, NJ, USA

Michael Haya Chemical Process Development, Global Product Development and Supply, Bristol Myers Squibb Company, New Brunswick, NJ, USA

Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugate

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugate

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date